Citadel Advisors’s Larimar Therapeutics LRMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$220K	Buy	48,800 +31,300	+179%	+$125K	﹤0.01%	11224
2025 Q4	$66.7K	Sell	17,500 -82,100	-82%	-$319K	﹤0.01%	11895
2025 Q3	$322K	Buy	99,600 +39,600	+66%	+$148K	﹤0.01%	10197
2025 Q2	$173K	Buy	60,000 +44,800	+295%	+$104K	﹤0.01%	10818
2025 Q1	$32.7K	Sell	15,200 -15,600	-51%	-$49.3K	﹤0.01%	12737
2024 Q4	$119K	Buy	30,800 +1,400	+5%	+$9.24K	﹤0.01%	11204
2024 Q3	$193K	Buy	29,400 +27,100	+1,178%	+$218K	﹤0.01%	10210
2024 Q2	$16.7K	Sell	2,300 -15,900	-87%	-$122K	﹤0.01%	12776
2024 Q1	$138K	Buy	18,200 +18,000	+9,000%	+$140K	﹤0.01%	10891
2023 Q4	$910	Sell	200 -500	-71%	-$1.69K	﹤0.01%	13918
2023 Q3	$2.77K	Sell	700 -700	-50%	-$2.65K	﹤0.01%	13673
2023 Q2	$4.38K	Buy	1,400 +700	+100%	+$2.86K	﹤0.01%	13601
2023 Q1	$3.17K	Buy	+700	New	+$3.66K	﹤0.01%	14065
2016 Q3	–	Sell	-867	Closed	-$62K	–	7520
2016 Q2	$62K	Buy	+867	New	+$68.5K	﹤0.01%	6355
2016 Q1	–	Sell	-192	Closed	-$14K	–	7444
2015 Q4	$14K	Sell	192 -75	-28%	-$12K	﹤0.01%	8142
2015 Q3	$102K	Buy	+267	New	+$120K	﹤0.01%	6941